Viewing Study NCT06388915



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06388915
Status: COMPLETED
Last Update Posted: 2024-04-29
First Post: 2024-04-25

Brief Title: A Retrospective Cohort Study of 15 Cases of Pelvic Fractures Complicated by Morel-Lavallee Lesion
Sponsor: Weikang Chen
Organization: Fujian Provincial Hospital

Study Overview

Official Title: A Retrospective Cohort Study of 15 Cases of Pelvic Fractures Complicated by Morel-Lavallee Lesion
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Some related factors of pelvic fracture and Morel-Lavallee injury MLL are preliminarily discussed which provides some preliminary references for early clinical detection and research of such injuries
Detailed Description: Inclusion criteria 1 The clinical symptoms are consistent with the diagnosis of pelvic fracture and the diagnosis is confirmed by imaging including emergency or sub-emergency CT data within 72 hours after injury 2 The symptoms of the diagnosis of MLL were pain and swelling at the site of occurrence a sense of soft tissue fluctuation found on physical examination and a complete process of puncture drainage negative pressure suction therapy 3 The patients and their families have given informed consent to this study and signed the informed consent form which meets the ethical requirements

Exclusion criteria 1 Incomplete imaging data especially the lack of emergency or sub-emergency CT data within 72 hours after injury 2 Cases of other severe lower limb fractures such as femur and trochanter and lower limb fractures combined with MLL injury have been reported in the literature

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None